MOUNT SINAI MAKES AN IMPORTANT DIABETES DISCOVERY

Sep 23, 2014

By Michael Kramer

Share on

A potentially ground-breaking discovery about diabetes – from Toronto’s Mount Sinai Hospital.

A clinical trial has found that a drug – Liraglutide – which mimics a key hormone controlling sugar metabolism – can also preserve pancreatic function and the production of insulin,  for at least 48 weeks – in patients with diabetes.

Type 2 diabetes typically worsens progressively – as the ability of the pancreas to produce insulin gradually declines.

The medication is usually reserved for later stages of the disease – but the study results suggest that it should be used much earlier in the course of diabetes – when there is more pancreatic function to preserve.

Principal investigator Doctor Ravi Retnakaran says this discovery has the potential to change the long-term prognosis –  for type 2 diabetes.

The findings were just published in the journal “Diabetes Care.”

Join Our Fan Club
Coverage Area
Downtown Toronto
96.7FM
Toronto HD
96.3 HD-2
Kingston to Windsor, Parry Sound to Pittsburgh
AM740
ZoomerRadio Logo

Recently Played: